HTLV-1 infection: what determines the risk of inflammatory disease?
- 1 October 2012
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 20 (10) , 494-500
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Human T Cell Leukemia Virus Type 1 Tax Inhibits Innate Antiviral Signaling via NF-κB-Dependent Induction of SOCS1Journal of Virology, 2011
- Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neuronsGlia, 2010
- Epidemiology, Treatment, and Prevention of Human T-Cell Leukemia Virus Type 1-Associated DiseasesClinical Microbiology Reviews, 2010
- A Genomic Approach to Human Autoimmune DiseasesAnnual Review of Immunology, 2010
- Interferon signature gene expression is correlated with autoantibody profiles in patients with incomplete lupus syndromesClinical and Experimental Immunology, 2009
- Stromal Cell-Mediated Suppression of Human T-Cell Leukemia Virus Type 1 Expression In Vitro and In Vivo by Type I InterferonJournal of Virology, 2009
- How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targetsImmunological Reviews, 2008
- HIV-1 immunopathogenesis: How good interferon turns badClinical Immunology, 2007
- Differential expression of IFN-α and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patientsProceedings of the National Academy of Sciences, 2006
- Stereotyped and specific gene expression programs in human innate immune responses to bacteriaProceedings of the National Academy of Sciences, 2002